ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
PolyPid Announces Start of Phase 3 Clinical Trial of D-PLEX100
March 04, 2020PolyPid announced that the first patient has been enrolled and randomized in a Phase 3 clinical trial called SHIELD (Surgical site Hospital acquired Infection prEvention with Local D-plex). -
Astellas, Sunovion and Shield breach ABPI Code
December 19, 2018The Prescription Medicines Code of Practice Authority (PMCPA) has announced that Astellas Pharmaceuticals, Sunovion Pharmaceuticals and Shield Therapeutics have all breached the Association -
Shield expecting US decision on Feraccru in July
December 14, 2018Shield Therapeutics has revealed that the US Food and Drug Administration will make a decision on its application to market Feraccru in the US by July 27 next year. -
Shield’s Feraccru accepted for review in the US
December 06, 2018Shield Therapeutics’ iron deficiency drug Feraccru has been accepted for review by the US Food and Drug Administration (FDA).
Pharma Sources Insight January 2025
